CCL2 and COVID-19: In COVID-19 patients, excessive release of cytokine, including IL1-β, IL-2, IL-6, IL-7, IL-8, IP10, MCP1, MIP1A, and tumor necrosis factor-α (TNF-α), exacerbated COVID-19 manifestation (2, 52, 53).